Cancer & Metabolism

2017 Call for Papers is Open!

New Content Item

Cancer & Metabolism invites all relevant researchers and professionals to engage in the ever-expanding scope of cancer and metabolism and submit their manuscripts today. Our editorial board consists of global leaders in the field who encourage submissions of many different article types, including Short Communications and Rapid Reports--prioritizing quality and efficiency.

The journal welcomes studies on all aspects of the relationship between cancer and metabolism, including:

- Molecular biology and genetics of cancer metabolism
- Whole-body metabolism, including diabetes and obesity, in relation to cancer

- Metabolomics in relation to cancer

- Metabolism-based imaging

- Preclinical and clinical studies of metabolism-related cancer therapies

Editors' profiles

Chi Van Dang, Editor Emeritus

Chi Dang is a professor, physician-researcher, renowned cancer biologist and hematologist-oncologist, who serves as director of the Abramson Cancer Center at the University of Pennsylvania.

"After several decades of profound advances in our understanding of the genetics and molecular biology of cancer, it has become self-evident that metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. The obesity pandemic connected to increased cancer risk further underscore the importance of a richer understanding of cancer and organismal metabolism. In this regard, Cancer & Metabolism is launched uniquely to fulfill the needs of a burgeoning field which is at the crossroads of many scientific disciplines."

Michael Pollak, co-Editor-in-Chief

Michael Pollak is an internationally recognized expert in cancer endocrinology at the Lady Davis Institute for Medical Research of McGill University and a clinical oncologist at the Jewish General Hospital, Quebec, Canada.

"Cancer & Metabolism will provide a forum for rapid dissemination of research findings concerning metabolic factors that influence cancer risk and cancer pathophysiology, and cancer treatment. The scope of the Journal will allow for an interdisciplinary readership including cancer biologists, endocrinologists, oncologists, clinical trialists and population scientists."

Supplements

Cancer & Metabolism publishes selected collections of research articles, conference proceedings, reviews and reports as supplements. While we build our new sites all supplements will be available here.

Editors-in-Chief

Michael Pollak, McGill University, Canada

Matthew Vander Heiden, Massachusetts Institute of Technology, USA

Senior Editors

Kevin Brindle, University of Cambridge, UK
Navdeep Chandel, Northwestern University, USA
Ralph DeBerardinis, University of Texas Southwestern Medical Center, USA
Eyal Gottlieb, Beatson Institute for Cancer Research, UK

Editor Emeritus

Chi Van Dang, University of Pennsylvania, USA

Aims and scope

Cancer & Metabolism welcomes studies on all aspects of the relationship between cancer including Molecular biology and genetics of cancer.

Efficient peer review

We recognize that scientifically sound, high-quality manuscripts often receive negative decisions from high-impact journals on the basis of perceived general interest levels or the absence of extensive mechanisms supporting research hypotheses. As a niche journal, Cancer & Metabolism will consider rapid publication of such manuscripts if they are submitted together with the original peer reviewer reports, letter of rejection, and a brief rebuttal.

Featured article: Mathematical models of cancer metabolism

This review highlights the recent advances on the mathematical models of cancer metabolism.

Article collections

Cross journal article collection

Mitochondria

Guest edited by Navdeep Chandel (on behalf of Cancer & Metabolism), Martin Brand, Andrew Murray, Jodi Nunnari and Peter Walter, this cross journal collection focuses on all aspects of mitochondrial function in cancer and metabolism.